HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philippe Beauchemin Selected Research

Philippe Beauchemin Research Topics

Disease

3Multiple Sclerosis
02/2024 - 12/2016
2Infections
02/2024 - 01/2022
1Chronic Progressive Multiple Sclerosis
02/2024
1Agammaglobulinemia (Hypogammaglobulinemia)
02/2024
1Demyelinating Diseases (Demyelinating Disease)
08/2023
1Leukocytosis (Pleocytosis)
08/2023
1Disease Progression
08/2023
1Vitelliform Macular Dystrophy
08/2023
1Guillain-Barre Syndrome
06/2022
1Vasculitis (Vasculitides)
06/2022
1Primary Myelofibrosis (Myelosclerosis)
06/2022
1Relapsing-Remitting Multiple Sclerosis
06/2022
1Autoimmune Diseases (Autoimmune Disease)
06/2022
1COVID-19
01/2022
1Brain Diseases (Brain Disorder)
01/2022
1Neuromyelitis Optica (Devic's Disease)
12/2016
1Rheumatoid Arthritis
02/2016

Drug/Important Bio-Agent (IBA)

2tocilizumab (atlizumab)FDA Link
12/2016 - 02/2016
1ocrelizumabIBA
02/2024
1Immunoglobulin A (IgA)IBA
02/2024
1Immunoglobulin M (IgM)IBA
02/2024
1Immunoglobulin G (IgG)IBA
02/2024
1Myelin-Oligodendrocyte GlycoproteinIBA
08/2023
1Oligoclonal BandsIBA
08/2023
12- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
12/2022
1Alemtuzumab (Campath)FDA Link
06/2022
1VaccinesIBA
01/2022
1COVID-19 VaccinesIBA
01/2022

Therapy/Procedure

3Therapeutics
02/2024 - 02/2016